
Why Parents Are Refusing the Vitamin K Shot
Jaspreet Loyal, MD, MS, of Yale explains why vitamin K shot refusals are rising and how clinicians counsel hesitant parents in the newborn nursery.
Refusals of the vitamin K shot, which is predominantly given at birth to support newborn blood clotting,
Overall, vitamin K refusals rose 77%, from 2.92% in 2017 to 5.18% in 2024,1 and although refusals remain relatively uncommon, the increase is enough to warrant concern from clinicians, especially pediatricians and neonatologists who already carry the brunt of broader vaccine hesitancy. Loyal described VKDB as a low-likelihood but high-risk event. She explained that her hospital updated its newborn nursery templates to clearly document refusals, so if the infant later presents with bleeding elsewhere, such as an emergency department, clinicians know to consider VKDB. Loyal also said her colleagues have told her that counseling families who refuse the shot has prolonged their workdays and taken time away from other newborn care topics.
“We're doing our best one-on-one, trying to figure out people's reasons, working on building trust, rapport, and being this guide, but on a large scale it's a heavy lift, and we're not only talking about vitamin K,” she said. “We're talking about hepatitis B vaccine. We're talking about nirsevimab [Beyfortus; Sanofi and AstraZeneca]. We're talking about refusing the hearing screen and just like routine newborn things.”
This trend is also not new; prior research analyzed refusals from 2013 to 2019.1 However, Loyal said the COVID-19 pandemic could, in theory, explain part of the growing mistrust she sees among parents who decline the shot.
“I'm just afraid that something dramatic needs to happen for people to see that this is important,” she concluded.
Listen above or on one of these podcast services:
References
1. McCrear S. Vitamin K refusals are rising: what payers need to know. AJMC®. September 18, 2026. Accessed October 6, 2026.
Related to this article



